Working capital increased 24.6%
Working capital changed +24.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$627.9M→$782.2M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →BDC financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents increased 21.1%
Cash & equivalents changed +21.1% from the comparable as-filed period.
$314.3M→$380.7M3 prior comparisons
Working capital / assets moved 516 bp lower
Working capital / assets changed -516 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
18.27%→13.11%3 prior comparisons
Gross profit increased 28.7%
Gross profit changed +28.7% from the comparable as-filed period.
$263.2M→$338.8M2 prior comparisons
Stock-based compensation increased 38.3%
Stock-based compensation changed +38.3% from the comparable as-filed period.
$8.0M→$11.1M2 prior comparisons
Capital expenditure increased 20.5%
Capital expenditure changed +20.5% from the comparable as-filed period.
$39.7M→$47.8M2 prior comparisons
Inventory / revenue moved 105 bp higher
Inventory / revenue changed +105 basis points from the comparable as-filed period.
56.42%→57.46%2 prior comparisons
Capex / revenue moved 73 bp lower
Capex / revenue changed -73 basis points from the comparable as-filed period.
5.68%→4.95%2 prior comparisons
Operating cash-flow margin moved 162 bp lower
Operating cash-flow margin changed -162 basis points from the comparable as-filed period.
15.04%→13.42%2 prior comparisons
Shares outstanding decreased 0.5%
Shares outstanding changed -0.5% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
39,300,209→39,100,0238 prior comparisons
Current ratio decreased 8.6%
Current ratio changed -8.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
1.99→1.824 prior comparisons
Free-cash-flow margin moved 88 bp lower
Free-cash-flow margin changed -88 basis points from the comparable as-filed period.
9.36%→8.47%2 prior comparisons
R&D / revenue moved 87 bp higher
R&D / revenue changed +87 basis points from the comparable as-filed period.
4.85%→5.72%2 prior comparisons
SBC / revenue moved 0 bp lower
SBC / revenue changed -0 basis points from the comparable as-filed period.
1.15%→1.15%2 prior comparisons
Operating margin moved 144 bp higher
Operating margin changed +144 basis points from the comparable as-filed period.
11.79%→13.23%2 prior comparisons
Capital expenditure increased 61.7%
Capital expenditure changed +61.7% from the comparable as-filed period.
$25.2M→$40.7M3 prior comparisons
Working capital increased 22.1%
Working capital changed +22.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$607.0M→$741.1M4 prior comparisons
Stock-based compensation increased 32.4%
Stock-based compensation changed +32.4% from the comparable as-filed period.
$6.8M→$9.0M3 prior comparisons
Revenue increased 11.6%
Revenue changed +11.6% from the comparable as-filed period.
$672.0M→$750.2M2 prior comparisons
Working capital / assets moved 292 bp higher
Working capital / assets changed +292 basis points from the comparable as-filed period.
17.86%→20.77%3 prior comparisons
Cash & equivalents increased 15.6%
Cash & equivalents changed +15.6% from the comparable as-filed period.
$301.5M→$348.7M3 prior comparisons
Current assets increased 14.0%
Current assets changed +14.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.2B→$1.4B4 prior comparisons
Gross margin moved 66 bp higher
Gross margin changed +66 basis points from the comparable as-filed period.
38.48%→39.14%2 prior comparisons
Free-cash-flow margin moved 334 bp higher
Free-cash-flow margin changed +334 basis points from the comparable as-filed period.
8.46%→11.81%2 prior comparisons
Operating cash-flow margin moved 502 bp higher
Operating cash-flow margin changed +502 basis points from the comparable as-filed period.
12.21%→17.23%2 prior comparisons
Current liabilities increased 6.0%
Current liabilities changed +6.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$615.6M→$652.8M4 prior comparisons
Capex / revenue moved 168 bp higher
Capex / revenue changed +168 basis points from the comparable as-filed period.
3.74%→5.42%2 prior comparisons
Inventory / revenue moved 179 bp lower
Inventory / revenue changed -179 basis points from the comparable as-filed period.
57.86%→56.07%2 prior comparisons
Total assets increased 4.9%
Total assets changed +4.9% from the comparable as-filed period.
$3.4B→$3.6B3 prior comparisons
Selling, general & administrative increased 12.1%
Selling, general & administrative changed +12.1% from the comparable as-filed period.
$131.9M→$147.8M2 prior comparisons
Cost of revenue increased 10.4%
Cost of revenue changed +10.4% from the comparable as-filed period.
$413.4M→$456.5M2 prior comparisons
Gross profit increased 13.6%
Gross profit changed +13.6% from the comparable as-filed period.
$258.6M→$293.6M2 prior comparisons
Noncurrent long-term debt decreased 3.2%
Noncurrent long-term debt changed -3.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$1.3B→$1.2B4 prior comparisons
Shares outstanding decreased 1.4%
Shares outstanding changed -1.4% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
39,619,837→39,078,1918 prior comparisons
Inventory increased 8.2%
Inventory changed +8.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$388.8M→$420.6M4 prior comparisons
Current ratio increased 7.5%
Current ratio changed +7.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
1.99→2.144 prior comparisons
Research & development decreased 6.6%
Research & development changed -6.6% from the comparable as-filed period.
$33.9M→$31.7M2 prior comparisons
SBC / revenue moved 19 bp higher
SBC / revenue changed +19 basis points from the comparable as-filed period.
1.02%→1.21%2 prior comparisons
R&D / revenue moved 82 bp lower
R&D / revenue changed -82 basis points from the comparable as-filed period.
5.05%→4.23%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.